<--- Back to Details
First PageDocument Content
Date: 2017-05-01 03:53:28

Application of Natural Resources to Drug Discovery in Eisai Research and Development of Eribulin mesylate Katsuya Tagami, Eisai Co., Ltd. Eribuin mesylate is a first-in class, non-taxane microtubule dynamics inhibitor th

Add to Reading List

Source URL: apac-asia.com

Download Document from Source Website

File Size: 53,67 KB

Share Document on Facebook

Similar Documents